DS
XENE icon

DRW Securities’s Xenon Pharmaceuticals XENE Stock Holding History

DRW Securities’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$318K Buy
+5,461
New +$252K ﹤0.01% 855
2025
Q4 		– Sell
-9,273
Closed -$374K – 1755
2025
Q3 		$374K Buy
+9,273
New +$327K 0.01% 738
2018
Q2 		– Sell
-30,000
Closed -$147K – 175
2018
Q1 		$147K Hold
30,000
– – 0.01% 134
2017
Q4 		$85K Buy
+30,000
New +$81.6K 0.01% 437

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DRW Securities's XENE Position: Q1 2026 in Review

DRW Securities opened a new position in Xenon Pharmaceuticals (XENE) in Q1 2026: 5,461 shares worth $318K. The stake represents ﹤0.01% of the portfolio and ranks #855 among its holdings. This is a return to the name: DRW Securities previously reported a position in XENE as recently as Q3 2025.

DRW Securities first reported a position in XENE in Q4 2017 and has held it in 4 quarters since. The position peaked at $374K in Q3 2025. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.

  • DRW Securities held 5,461 shares of Xenon Pharmaceuticals worth $318K as of Q1 2026.
  • Xenon Pharmaceuticals was a new DRW Securities position in Q1 2026.
  • Xenon Pharmaceuticals made up ﹤0.01% of DRW Securities's portfolio in Q1 2026, its #855 holding.
  • DRW Securities first reported a position in Xenon Pharmaceuticals in Q4 2017 and has held it in 4 quarters since.
  • DRW Securities's Xenon Pharmaceuticals position peaked at $374K in Q3 2025.
  • 290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.